New paper on potential therapy against SARS-CoV-2
Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and...
top of page
Search
landaulabnyu
- Aug 25, 2020
- 1 min
Landau Lab collaborates with Carisma Therapeutics!
CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of...
55 views0 comments
landaulabnyu
- Mar 25, 2019
- 1 min
New Paper in Press!
Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice Thomas D. Norton1,2*, Anjie Zhen3*, Takuya...
54 views0 comments
landaulabnyu
- Mar 25, 2019
- 1 min
Battle of Amfar featuring Dr. Landau
Dr. Nathaniel Landau appeared in the Documentary “The Battle of AmfAR”, which premiered on Dec. 2, 9pm on HBO. The documentary is...
27 views0 comments
landaulabnyu
- Mar 25, 2019
- 1 min
TWiV podcast with Dr. Landau
Dr. Landau joins the TWiV team to discuss restriction of HIV replication by SAMHD1, and a viral antagonist that can be used to produce a...
25 views0 comments
landaulabnyu
- Feb 1, 2019
- 1 min
Landau Lab's work on DC vaccine against HIV featured in the NYULH Magazine
Check out the article in the spring 2019 issue of the NYU Langone Health magazine. https://nyulangone.org/news/nyu-school-medicine-resea...
7 views0 comments
bottom of page